Abstract
Get full access to this article
View all access options for this article.
References
1.
Smolders
J
Hupperts
R
Barkhof
F
Grimaldi
LM
Holmoy
T
Killestein
J
., SOLAR study group. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a:a Phase II, multicenter, double-blind, randomized, placebo-controlled trial . J Neurol Sci
2011 ; 311 : 44 –9 .
2.
Dörr
J
Ohlraun
S
Skarabis
H
Paul
F
. Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial . Trials . 2012 ; 13 : 15 .
3.
http://www.msra.org.au/vitamin-d-prevention-trial-ms-will-commence-2012-0.
Accessed 21st July 2012 .
4.
Hutchinson
M
Zajicek
J
. Clinically isolated syndrome: a protected zone for trials of new therapies?
Mult Scler
2010 ; 16 : 754 –5 .